Loading clinical trials...
Loading clinical trials...
PREPARE STUDY: PRevalence of the Eosinophilic Phenotype Among SeveRE Asthma Patients in AstraZeneca International Region. A Multinational, Cross-Sectional, Multicenter Study
Conditions
Locations
18
Argentina
Research Site
Buenos Aires, Argentina
Research Site
Rosario, Argentina
Research Site
Curicó, Chile
Research Site
Santiago, Chile
Research Site
Barranquilla, Colombia
Research Site
Bogotá, Colombia
Start Date
May 15, 2019
Primary Completion Date
November 26, 2020
Completion Date
November 26, 2020
Last Updated
January 29, 2021
NCT05691218
NCT06681545
NCT06385236
NCT07343661
NCT06916104
NCT07403487
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions